Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to reflect a reduction in study locations from 203 to 180, with several specific locations removed, including sites in Arizona, California, Florida, Minnesota, New York, Ohio, Oregon, Texas, Virginia, and various international locations. Additionally, the registry identifier has been updated, and new information regarding data sharing has been added.SummaryDifference7%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
- Check46 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check60 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check67 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.1%
Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.